Subir material

Suba sus trabajos a SEDICI, para mejorar notoriamente su visibilidad e impacto

 

Mostrar el registro sencillo del ítem

dc.date.accessioned 2021-09-06T15:04:26Z
dc.date.available 2021-09-06T15:04:26Z
dc.date.issued 2020-03-26
dc.identifier.uri http://sedici.unlp.edu.ar/handle/10915/124182
dc.description.abstract Based on some publications that associate SARS-CoV-2 infection with the use of anti-hypertensive drug groups such as angiotensin-converting-enzyme inhibitors (e.g. enalapril) or angiotensin II receptor blockers (e.g. losartan), many patients from South America, Central America or Spain, have stopped or intend to interrupt their treatments with these drugs. Hence, it may exist ominous consequences due to this drop out. For this reason, it is necessary to quickly warn about this situation and the risks associated with it. en
dc.format.extent 105-106 es
dc.language en es
dc.subject ACE es
dc.subject ATII-RB es
dc.subject Anti-hypertensive drugs es
dc.subject COVID-19 es
dc.subject SARS-CoV-2 es
dc.title Facts and reflections on COVID-19 and anti-hypertensives drugs en
dc.type Articulo es
sedici.identifier.other pmid:32213760 es
sedici.identifier.other doi:10.5582/ddt.2020.01017 es
sedici.identifier.issn 1881-784X es
sedici.identifier.issn 1881-7831 es
sedici.creator.person Marín, Gustavo Horacio es
sedici.subject.materias Ciencias Médicas es
sedici.description.fulltext true es
mods.originInfo.place Facultad de Ciencias Médicas es
mods.originInfo.place Consejo Nacional de Investigaciones Científicas y Técnicas es
sedici.subtype Articulo es
sedici.rights.license Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
sedici.rights.uri http://creativecommons.org/licenses/by-nc-sa/4.0/
sedici.description.peerReview peer-review es
sedici.relation.journalTitle Drug Discoveries & Therapeutics es
sedici.relation.journalVolumeAndIssue vol. 14, no. 2 es


Descargar archivos

Thumbnail
Documento
Descargar archivo (190.1Kb) - PDF

Este ítem aparece en la(s) siguiente(s) colección(ones)

Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) Excepto donde se diga explícitamente, este item se publica bajo la siguiente licencia Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)